Stock Events

Stock Events

Ulisse Biomed S.p.a. 

€0.180000
2
+€0.05+35.75% Thursday 08:23

Statistics

Day High
0.137
Day Low
0.1366
52W High
0.137
52W Low
0.1366
Volume
5,809
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

16OctExpected
Q2 2024
Q1 2025
Q3 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-773.44%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
768,000Revenue
-5.94MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alcon
ALC.SW
Mkt Cap26.55B
Alcon specializes in eye care products, competing directly in the biomed sector with Ulisse Biomed's focus on healthcare solutions.
Resmed
RMD
Mkt Cap32.94B
ResMed is a leader in the medical devices for respiratory disorders, overlapping with Ulisse Biomed's medical device offerings.
Stryker
SYK
Mkt Cap116.27B
Stryker Corporation is involved in medical technologies, including surgical equipment, which competes with Ulisse Biomed's medical device innovations.
Medtronic
MDT
Mkt Cap120.46B
Medtronic plc offers medical technologies, services, and solutions, directly competing with Ulisse Biomed in the healthcare products market.
Abbott Laboratories
ABT
Mkt Cap187.45B
Abbott Laboratories operates in multiple segments including medical devices and diagnostics, similar to Ulisse Biomed's market.
Intuitive Surgical
ISRG
Mkt Cap129.55B
Intuitive Surgical, Inc. provides robotic-assisted surgical technologies, competing in the innovative medical device sector like Ulisse Biomed.
Boston Scientific
BSX
Mkt Cap69.27B
Boston Scientific Corporation develops medical devices that are in direct competition with some of Ulisse Biomed's product lines.
Baxter International
BAX
Mkt Cap13.35B
Baxter International Inc. offers a range of hospital and renal products, competing with Ulisse Biomed in the healthcare solutions space.
Zimmer Biomet
ZBH
Mkt Cap18.71B
Zimmer Biomet Holdings, Inc. specializes in musculoskeletal healthcare, which competes with Ulisse Biomed's medical technologies.
Edwards Lifesciences
EW
Mkt Cap51.82B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the medical devices sector with Ulisse Biomed.

About

Helyx Industries S.p.A., a healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy. The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); CoronaMelt, a diagnostic test for Sars- CoV-2; CoronaMelt Var, a diagnostic assay for the detection and genotyping of Sars-CoV-2 variants; and UlisseFaster, a reagent for the pre-treatment of biological samples. It provides various tests and reagents for sexually transmitted diseases and HPV. In addition, the company’s platforms also comprise NanoHybrid, a platform to detect specific antibodies and protein analytes directly from serum or whole blood; and Aptavir platform to develop and produce synthetic nucleic acid molecules to limit the infectivity of pathogens. The company was formerly known as Ulisse Biomed S.p.A. and change its name to Helyx Industries S.p.A. in December 2025. Helyx Industries S.p.A. was founded in 2015 and is based in Udine, Italy.
Show more...
CEO
Nicola Basile
Employees
22
Country
Italy
ISIN
IT0005453789

Listings

STU
DE
8XX.STU
MI
IT
HLX.MI
MI
IT
WHLX26.MI

0 Comments

Share your thoughts

FAQ

What is Ulisse Biomed S.p.a. stock price today?▼
The current price of WUBM26.MI is €0.18 EUR — it has increased by +35.75% in the past 24 hours. Watch Ulisse Biomed S.p.a. stock price performance more closely on the chart.
What is Ulisse Biomed S.p.a. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Borsa Italiana exchange Ulisse Biomed S.p.a. stocks are traded under the ticker WUBM26.MI.
Is Ulisse Biomed S.p.a. stock price growing?▼
WUBM26.MI stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Ulisse Biomed S.p.a. has showed a +140% increase.
What is Ulisse Biomed S.p.a. revenue for the last year?▼
Ulisse Biomed S.p.a. revenue for the last year amounts to 768,000 EUR.
What is Ulisse Biomed S.p.a. net income for the last year?▼
WUBM26.MI net income for the last year is -5.94M EUR.
How many employees does Ulisse Biomed S.p.a. have?▼
As of September 07, 2026, the company has 22 employees.
In which sector is Ulisse Biomed S.p.a. located?▼
Ulisse Biomed S.p.a. operates in the Health & Wellness sector.
When did Ulisse Biomed S.p.a. complete a stock split?▼
The last stock split for Ulisse Biomed S.p.a. was on January 03, 2022 with a ratio of 9:8.
Where is Ulisse Biomed S.p.a. headquartered?▼
Ulisse Biomed S.p.a. is headquartered in Udine, Italy.